mash and glp 1 Reversing fibrosis in metabolic dysfunction–associated steatohepatitis—beyond telling patients to lose weight Exploring the Potential of GLP-1
Description
F., Ivanov, I., Mills, D
Chatterjee S, et al
He began his career at VC firm TA Associates
This broad pleiotropy was supported by associations observed in the 23andMe database (Supplementary Table 19)
However, it is important to remember that individual results will vary, with some people losing less weight and others losing more
Pancreatitis risk is another consideration
